(Q34384114)

1 August 2017

1 reference

title

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus (English)

1 reference

1 August 2017

1 reference

1 reference

Ginsberg HN

1

1 reference

PubMed ID

11576520

1 August 2017

Illingworth DR

series ordinal

2

1 reference

PubMed ID

11576520

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Cardiology

1 August 2017

1 reference

1 August 2017

88

1 reference

1 August 2017

6A

1 reference

1 August 2017

9H-15H

1 reference

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

7 January 2021

Lipoprotein physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Hyperlipidemia and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Atherosclerosis and arterial influx of lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Postprandial lipoprotein metabolism and atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Management of dyslipidemia in adults with diabetes. American Diabetes Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Hypertriglyceridemia: a contraindication to the use of bile acid binding resins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Management of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Effects of statins on triglyceride metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Pravastatin Therapy and the Risk of Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Clinical results with gemfibrozil and background to the Helsinki Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Effects of fibric acid derivatives and metformin on postprandial lipemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901831-8

10.1016/S0002-9149(01)01831-8

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11576520